Dupilumab Alters Both the Bacterial and Fungal Skin Microbiomes of Patients with Atopic Dermatitis

Dupilumab Alters Both the Bacterial and Fungal Skin Microbiomes of Patients with Atopic Dermatitis

The skin microbiome at lesion sites in patients with atopic dermatitis (AD) is characterized by dysbiosis. Although the administration of dupilumab, an IL-4Rα inhibitor, improves dysbiosis in the bacterial microbiome, information regarding the fungal microbiome remains limited. This study administer...

Full description

Bibliographic Details
Main Authors: Naoka Umemoto, Maki Kakurai, Takanao Matsumoto, Kenta Mizuno, Otomi Cho, Takashi Sugita, Toshio Demitsu
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Microorganisms
Subjects:
atopic dermatitis
dupilumab
dysbiosis
<i>Malassezia</i>
skin microbiome
<i>Staphylococcus aureus</i>
Online Access:https://www.mdpi.com/2076-2607/12/1/224

Internet

https://www.mdpi.com/2076-2607/12/1/224

Similar Items